Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Net Income: 2022-2025

Historic Net Income for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to -$78.4 million.

  • Praxis Precision Medicines' Net Income fell 37.87% to -$78.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$293.1 million, marking a year-over-year decrease of 78.71%. This contributed to the annual value of -$200.2 million for FY2024, which is 58.39% down from last year.
  • Latest data reveals that Praxis Precision Medicines reported Net Income of -$78.4 million as of Q3 2025, which was down 3.01% from -$76.1 million recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' Net Income ranged from a high of -$25.5 million in Q3 2023 and a low of -$78.4 million during Q3 2025.
  • Over the past 3 years, Praxis Precision Medicines' median Net Income value was -$41.9 million (recorded in 2024), while the average stood at -$50.5 million.
  • Its Net Income has fluctuated over the past 5 years, first soared by 44.67% in 2023, then plummeted by 130.01% in 2024.
  • Quarterly analysis of 4 years shows Praxis Precision Medicines' Net Income stood at -$41.5 million in 2022, then skyrocketed by 32.92% to -$27.8 million in 2023, then tumbled by 130.01% to -$64.0 million in 2024, then crashed by 37.87% to -$78.4 million in 2025.
  • Its Net Income was -$78.4 million in Q3 2025, compared to -$76.1 million in Q2 2025 and -$74.7 million in Q1 2025.